Neurology Flashcards

1
Q

Cognitive impairment

A

Difficulty with memory, thinking, concentration, and ability to read and write

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Delirium

A
  • Acute confusional state
  • State of an alteration of consciousness with reduced ability to focus, sustain or shift attention, causing cognitive or perceptual disturbance + ANS hyperactivity
  • Develops over short period of time (hrs-days) and fluctuated during the day
  • Reversible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of delirium

A

D = drugs (withdrawal/toxicity), OR dehydration
E = electrolyte imbalance, environment, enforced bedrest
L = level of pain
I = infection/inflammation (post surgery)
R = respiratory failure (hypoxia/hypercapnia)
I = impaction of faeces, imobility
U = urinary retention, IDC
M = metabolic disorder (LF, hypoglycaemia), MI, malnutrition
S = surgery, sensory impairment, sepsis, sleep deprivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology of delirium

A

Direct brain insult (e.g. hypoxia, hypoglycaemia, electrolyte imbalance)
* Disrupts NT systems causing cerebral dysfunction (reduced cholinergic function, increased dopamine, NA, glutamate)
* Injury also causes increased ICP, altered consciousness and delirium

Stress response
* Overstimulation of normally adaptive systemic and CNS responses to stress, trauma, anxiety, injury etc that affects cognition, mood, perception

Forms
1. exaggerated response to normal levels of pro-inflammatory mediators (cytokines, PGs) that affect NTs
2. Abnormally intense stress response & impaired HPA axis –> **high cortisol **–> disturbed circadian rhythm
* This disrupts neural networks in the reticular activating system (consciousness, wakefullness) of the upper brain stem, that projects into the cerebral cortex and limbic areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sickness behaviour

A

Adaptive changes in an individual during a period of illness used to conserve energy and minimise further insult (fatigue, anhedonia, reduced appetite)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Features of delirium

A

Acute or new deterioration

  • Disorientation
  • Memory impairment
  • Inattention
  • Disorganised thinking
  • Hallucinations
  • Motor abnormalities
  • Alt sleep-wake cycle
  • Alt consciousness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

4

Types of delirium

A

Hypoactive
* Most common but often missed, pt is withdrawn, drousy, quiet

Hyperactive
* Most recognised, pt is loud, restless, agitated, heightened arousal

Mixed
* Fluctuates throughout the day

Terminal
* Agitated delirium in last few days of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Delirium cognitive assessment & types

A
  1. Determine underlying cause
  2. Cognitive screening (AMT4 & single question in delirium (SQiD) for pts who
    * >65 (>45 ATSI), severe illness, risk of death, hip fracture, cognitive impairment

AMT4: age, DOB, year, hospital
SQiD: (family member) “has pt become more confused, sleepy or drowsy lately?”
* If >4 or SQiD+ –> AMT10 & CAM (confusion assessment method)

If AMT <8 = inform shift coordinator, organise CAM
If AMT >8 = monitor pt for changes in thinking and behaviour

CAM (confusion assessment method) = acute or fluctuating changes, inattention, ALOC, disorganised thinking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Routine specific assessments in suspected or confirmed delirium

A
  • Urinalysis - assess for UTI
  • BGL - assess for hypoglycaemia
  • O2 sat - for hypoxia
  • PaO2 - hypoxaemia
  • U&E - renal dysfunction & electrolyte imbalance
  • (respiratory symptoms) Sputum sample and chest x-ray - pulmonary infection or disorder causing hypoxia
  • RBC - low Hb, high WCC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nursing management for delirium

A

First identify cause to guide management

  • vitals 4 hrly, RBC, FNO
  • Monitor postural HoTN = BD lying and standing BP (benzo/antipsych lower BP)
  • FRAMP
  • Monitor for PI, nutrition and hydration esp in hypoactive
  • Ensure bladder isnt full, correct continence, regular UTI screening
  • Protect invasive lines, remove ASAP
  • Reduce stress (orientate, personal items in reach, family engagement)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Health promotion in delirium

A
  • determine personal information that may calm and orient pt, encourage family to bring in belongings
  • Encourage mobility and independence in ADLs, liase with PT and OT
  • Communication aids (liase with SP)
  • FRAMP = minimise risks
  • Prioritise non-pharm methods
  • Avoid bed rails
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Discharge planning in delirium

A
  • Involve the pt and carer in the plan
  • Liase with multidisciplinary team including consultant liaison psychiatry and social work
  • Assess for services required on discharge
  • Provide information for services, facilities, and delirium patient information leaflet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prevention of delirium

A
  • Promote sleep quality and avoid sleep disturbance
  • Limit polypharmacy & unecessary use of opioids, benzo and antihistamines
  • Orient person to PPT (clock, calender, conservations, activites)
  • Hydration
  • Mobility
  • Monitor for UTI, avoid unecessary catheterisation
  • Support nutrition
  • Assess for verbal and non verbal signs of pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Serenace

Haloperidol

Indication, drug class, mechanism of action, effect, route, s/e

A
  • Antipsychotic (oral, IV) used for acute confusion, hallucinations, delusions in delirium, schizophrenia and acute alcoholism
  • High affinity dopamine antagonist that blocks the postsynaptic dopamine transmission
  • Increased dopamine turnover (reduced concentration), reduced symptoms
  • S/E: HoTN, tachycardia, dystonia, drowsiness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Largactil

Chlorpromazine

Indication, drug class, mechanism of action, effect, route, s/e

A
  • Phenothiazine antipsychotic (oral) for short term management of agitation and behavioural disturbances in delirium and dementia
  • D2 receptor antagonist, inhibiting dopamine transmission and alleviating symptoms (not fully understood)
  • S/E: post HoTN, ECG changes, drowsiness, dry mouth, dystonia (anticholinergic effects)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pharmacotherapeutic management of delirium

A
  • Haloperidol & chlorpromazine are antipsychotics used to manage acute manifestations
  • BUT investigation into the cause is essential
  • Non pharm nursing management is essential including monitoring effectiveness of drug tx and s/e
17
Q

Dementia

A

Neurodegenerative condition causing progressive loss of cerebral function without impaired LOC
* Most common = Alzheimer’s

18
Q

Aetiology and pathophysiology of dementia

A
  • Combination of age, genetics, environment
  • Build up of amyloid and tau proteins that cause plaques and neurofibrillary tangles
  • Loss of neurons, shrinking of cerebral cortex, reduced # neuronal synapses
19
Q

Manifestations of dementia

A
  • Memory loss
  • Reduced concentration
  • Disorientation
  • Mood alterations
  • Aphasia (language dysfunction)
  • Apraxia (motor changes)
  • Agnosia (unable to process and recognise sensory information)
20
Q

Management of dementia

Dx, non-pharm mx

A
  • Diagnosis by history, manifestations, mental status exam and brain imaging
  • Determine cause (if possible) through lab and neuropsychological testing
  • Non-pharm management = promote remaining function throughe exercise, accomodate lost abilities, educating family
21
Q

3

Pharmacotherapeutic management of dementia

A
  • No medication to cure or prevent
  • Acetylcholinesterases (donepezil) = slows cognitive decline
  • Antipsychotics (chlorpromazine) = manage agitation or behavioural disturbances
  • antidepressants (dozepin) = depression associated with dementia
22
Q

(Aricept)

Donepezil

Indication, drug cass, mechanism, effect, route, s/e

A
  • Oral acetylcholinesterase inhibitor, that blocks the enzymatic breakdown of ACh, enhancing cholinergic function that is lost in alzheimers & responsible for many symptoms
  • S/e: diarrhoea, muscle cramps, N/V, fatigue, insomnia